Related references
Note: Only part of the references are listed.ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J. Pascual et al.
ANNALS OF ONCOLOGY (2022)
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
Simone Hettmer et al.
EUROPEAN JOURNAL OF CANCER (2022)
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Chenglong Chen et al.
CANCER LETTERS (2021)
Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
Sergio Ayala-Mar et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
Guohao Wang et al.
NATURE COMMUNICATIONS (2021)
The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
Lu Xie et al.
FRONTIERS IN ONCOLOGY (2021)
Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy
Veronica Aran et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
Yufan Qiu et al.
ONCOGENE (2021)
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma
Lorenza Di Guardo et al.
ONCOLOGIST (2021)
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Wenjun Xiong et al.
TRENDS IN CANCER (2021)
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Ayuko Hoshino et al.
CELL (2020)
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Jun Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy
Samantha M. Morrissey et al.
TRENDS IN CANCER (2020)
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
Yibo Fan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Yoshiyuki Suehara et al.
CLINICAL CANCER RESEARCH (2019)
Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
Chuling Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The role of exosomal PD-L1 in tumor progression and immunotherapy
Feiting Xie et al.
MOLECULAR CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1
Liangzhi Gong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
Bingxin Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S. Shulman et al.
BRITISH JOURNAL OF CANCER (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Marie-Nicole Theodoraki et al.
CLINICAL CANCER RESEARCH (2018)
Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells
Ryan M. Troyer et al.
EXPERIMENTAL CELL RESEARCH (2017)
Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment
Deyi Xiao et al.
CANCER LETTERS (2016)
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Mercedes Tkach et al.
CELL (2016)
Multimodal transfer of MDR by exosomes in human osteosarcoma
Elena Torreggiani et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway
Xiaoxia Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Pratistha Koirala et al.
SCIENTIFIC REPORTS (2016)
Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
Yan Li et al.
CELL RESEARCH (2015)
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sonia A. Melo et al.
NATURE (2015)
Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration
Keisuke Shimbo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms
Yinglong Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Extracellular Membrane Vesicles Derived from 143B Osteosarcoma Cells Contain Pro-Osteoclastogenic Cargo: A Novel Communication Mechanism in Osteosarcoma Bone Microenvironment
Rama Garimella et al.
TRANSLATIONAL ONCOLOGY (2014)
Extracellular heat shock protein HSP90β secreted by MG63 osteosarcoma cells inhibits activation of latent TGF-β1
Shigeki Suzuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Osteosarcoma of the pelvis in children and young adults: The St. Jude children's research hospital experience
R Saab et al.
CANCER (2005)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
